SCHEMBL30835271

SCHEMBL30835271

Clc1cnc(Br)c(CBr)n1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 4/20 0.33
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20189957 0.81 MAPKAPK2 (0.35) MAPKAPK2ALDH1A1
SCHEMBL23694612 0.77 ALDH1A1 (0.39) MAPKAPK2ALDH1A1
SCHEMBL28385522 0.74
SCHEMBL30121642 0.74
SCHEMBL30683717 0.72
SCHEMBL1731903 0.68
SCHEMBL19785236 0.68
SCHEMBL29734886 0.68
SCHEMBL21921215 0.68 LRRK2 (0.37) MAPKAPK2ALDH1A1
SCHEMBL1506464 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117836297-A (S) -1- (5- ((pyridin-3-yl) thio) pyrazin-2-yl) -4'H,6' H-spiro [ piperidine-4, 5 '-pyrrolo [1,2-B ] pyrazol ] -4' -amine derivatives and similar compounds as SHP2 inhibitors for the treatment of, for example, cancer 国家化学成分收集和筛选中心 2024-04-05 CN disclosed